A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Public ClinicalTrials.gov record NCT06047548. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Randomized Controlled Study to Evaluate the Efficacy and Safety of Tirzepatide Once Weekly 5 mg and/or Maximum Tolerated Dose Versus Placebo for Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (SURMOUNT-MAINTAIN)
Study identification
- NCT ID
- NCT06047548
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 441 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Tirzepatide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 19, 2023
- Primary completion
- Jan 19, 2026
- Completion
- Jan 19, 2026
- Last update posted
- Mar 24, 2026
2023 – 2026
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Research - Pelham | Pelham | Alabama | 35124 | — |
| Velocity Clinical Research, Westlake | Los Angeles | California | 90057 | — |
| Southern California Dermatology, Inc. | Santa Ana | California | 92701 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| New Horizon Research Center | Miami | Florida | 33165 | — |
| Oviedo Medical Research | Oviedo | Florida | 32765 | — |
| Rophe Adult and Pediatric Medicine/SKYCRNG | Union City | Georgia | 30291 | — |
| East-West Medical Research Institute | Honolulu | Hawaii | 96814 | — |
| Rocky Mountain Clinical Research | Idaho Falls | Idaho | 83404 | — |
| Asha Clinical Research - Munster | Hammond | Indiana | 46324 | — |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | 50265 | — |
| L-MARC Research Center | Louisville | Kentucky | 40213 | — |
| Prime Health and Wellness/SKYCRNG | Fayette | Mississippi | 39069 | — |
| Alliance for Multispecialty Research, LLC | Norman | Oklahoma | 73069 | — |
| WR-Clinsearch, LLC | Chattanooga | Tennessee | 37397 | — |
| The University of Texas Health Science Center at Houston | Bellaire | Texas | 77401 | — |
| Velocity Clinical Research, Dallas | Dallas | Texas | 75230 | — |
| Southern Endocrinology Associates | Mesquite | Texas | 75149 | — |
| Pinnacle Clinical Research | San Antonio | Texas | 78229 | — |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06047548, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2026 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06047548 live on ClinicalTrials.gov.